high priced drugs

Results 1 - 1 of 1Sort Results By: Published Date | Title | Company Name
Published By: IBM Watson Health     Published Date: Dec 20, 2018
In this webinar, experts discuss how data and analytics can be applied to improve health program outcomes and how social determinants of health affect risk. It includes a case study on how the application of advanced analytic methods helped to decipher the impact of high-priced specialty drugs on the overall population. The experts also address how artificial intelligence can drive better decision-making, improve population health and cut costs.
Tags : 
government, health and human services, artificial intelligence, data, cognitive insights, long-term care, case study, analytics, social program management, spm, healthcare technology, high-priced drugs, specialty drugs, population health
    
IBM Watson Health
Search      

Add Research

Get your company's research in the hands of targeted business professionals.

We use technologies such as cookies to understand how you use our site and to provide a better user experience. This includes personalizing content, using analytics and improving site operations. We may share your information about your use of our site with third parties in accordance with our Privacy Policy. You can change your cookie settings as described here at any time, but parts of our site may not function correctly without them. By continuing to use our site, you agree that we can save cookies on your device, unless you have disabled cookies.
I Accept